Cell therapy is an ever evolving industry in which clients creating new biological tools and technologies are being met with a number of complicated legal and regulatory challenges. From collaboration agreements to joint ventures to litigation strategies, we help clients navigate those challenges and even create opportunities.

Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum et, in quo bonorum tacimates. Id ius illud novum. Ius graeci nostrum id. Brute meliore ad vis, vel omnium perfecto est. Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum et, in quo bonorum tacimates. Id ius illud novum. Ius graeci nostrum id. Brute meliore ad vis, vel omnium perfecto. Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum et, in quo bonorum tacimates. Id ius illud novum. Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum.

Key contact

Contact

Experience

Latest articles

What others say

“Everyone makes a real effort to understand their clients, managing complex portfolios and relationships worldwide with minimum fuss and always within budget.”

WTR 1000, 2020

“A pleasure to work with, the team is technically excellent.”

WTR 1000, 2020

Alex Keenlyside is “a passionate media law and litigation specialist”

Chambers and Partners 2020

Alex Keenlyside “continues to build a reputation in the market for advising across a range of privacy, defamation and data protection matters”

Chambers and Partners 2020

“It is a high-quality team of practical thinkers who know what is needed in business.”

Chambers and Partners 2020

Recent rankings and awards

Life Sciences - Top tier
Chambers and Partners UK 2017

Pharmaceuticals and Biotechnology - Top tier
Legal 500 2017

Life Sciences Chambers and Partners 2017
Chambers and Partners Europe 2017